English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23358724      線上人數 : 468
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32683


    標題: The effects of human parvovirus VP1 unique region in a mouse model of allergic asthma
    作者: Shyh-Ren Chiang(蔣士仁)
    Lin, Chia-Yun
    Chen, Der-Yuan
    Tsai, Hui-Fang
    Lin, Xin-Ci
    Hsu, Tsai-Ching
    Tzang, Bor-Show
    貢獻者: Chi Mei Med Ctr, Dept Internal Med
    Chia Nan Univ Pharm & Sci, Dept Gen Sci
    Chung Shan Med Univ, Inst Biochem Microbiol & Immunol
    China Med Univ Hosp, Rheumatol & Immunol Ctr
    China Med Univ Hosp, Dept Med Res, Rheumat Dis Res Ctr
    China Med Univ, Sch Med
    Chung Shan Med Univ, Dept Med Lab & Biotechnol
    Chung Shan Med Univ Hosp, Clin Lab
    Chung Shan Med Univ, Immunol Res Ctr
    Chung Shan Med Univ, Sch Med, Dept Biochem
    關鍵字: RESPIRATORY-TRACT INFECTION
    HUMAN BOCAVIRUS
    B19 INFECTION
    IGE
    EXACERBATION
    VIRUSES
    PROTEIN
    HYPERREACTIVITY
    ASSOCIATION
    INDUCTION
    日期: 2019-05
    上傳時間: 2020-07-29 13:55:09 (UTC+8)
    出版者: PUBLIC LIBRARY SCIENCE
    摘要: Evidence has indicated that viral infection increases the risk of developing asthma. Although the association of human parvovirus B19 (B19V) or human bocavirus (HBoV) with respiratory diseases has been reported, little is known about the influence of the B19V-VP1u and HBoV-VP1u proteins on the symptoms of asthma. Herein, we investigated the systemic influence of subcutaneously injected B19V-VP1u and HBoV-VP1u recombinant proteins in an OVA-sensitized asthmatic mouse model. A significantly higher Penh ratio and IgE level were detected in the serum, bronchoalveolar lavage fluid (BALF) and the supernatant of a lymphocyte culture from mice treated with HBoV-VP1u or B19V-VP1u than in a lymphocyte culture from OVA-sensitized mice. Significantly higher levels of serum and BALF IgE, total IgG, IgG1, OVA-specific IgE and OVA-specific IgG1 were detected in mice treated with HBoV-VP1u or B19V-VP1u than in OVA-sensitized mice. Conversely, a significantly lower IgG2a level was detected in mice from the HBoV-VP1u or B19V-VP1u groups than in mice from the OVA group. The mice treated with HBoV-VP1u or B19V-VP1u exhibited more significant lung inflammatory indices, including elevated serum and BALF IL-4, IL-5, IL-10 and IL-13 levels; BALF lymphocyte, neutrophil and eosinophil counts, MMP-9 and MMP-2 activity; and the amount of lymphocyte infiltration, relative to those in the control mice or in those sensitized with OVA. These findings demonstrate that the subcutaneous injection of HBoV-VP1u or B19V-VP1u proteins in OVA-sensitized mice result in elevated asthmatic indices and suggest that human parvoviruses may increase the risk of developing airway inflammation in a mouse model of asthma.
    關聯: Plos One, v.14, n.5, e0216799
    顯示於類別:[通識教育中心] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    10.1371-journal.pone.0216799.pdf2875KbAdobe PDF342檢視/開啟
    index.html0KbHTML961檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋